C3H/HeJGpt
Mouse Model: C3H/HeJGpt
Strain Number: N000190
Spontaneous Mutation,Inbred strain
- Product Type:
- Quantity: - +
- Sex:
- Age:
- Genotype:
GemPharmatech Offers the World’s Largest Knockout and Conditional Knockout Library
With over 25,000 mouse models available and thousands of new strains developed annually, GemPharmatech has built the world’s largest knockout and conditional knockout resource library. Every model is generated using cutting-edge gene editing and validated at the genomic level to ensure reliability. Choosing GemPharmatech means more than acquiring a mouse model, it means partnering with a global leader committed to scientific rigor, competitive pricing, and timely delivery of the mice models your research requires.
| Strain Name: | C3H/HeJGpt |
| Strain Number: | N000190 |
| Official Symbol: | Tlr4,Pde6b,Gria4 |
| Strain Strategy: | N000190.C3H_HeJGpt strain info.pdf |
| NCBI Number: | 218981858714802 |
| Research Areas: | Tumor research |
| Strain Background: | [N000190] C3H/HeJ |
| Modification Type: | Spontaneous Mutation,Inbred strain |
| Inventory Status: | Live,Cryopreserved |
| Sale Status: | IF (Available for Distribution) |
| Health Status: | Specific pathogen free (SPF) |
| Publications: | 1. Photothermal Catalytic Reduction and Bone Tissue Engineering Towards a Three-in-One Therapy Strategy for Osteosarcoma. Adv Mater (2024)2. Bcl6 controls the stability and suppressive function of regulatory T cells in head and neck squamous cell carcinoma. Genes & Diseases (2024)3. KHSRP promotes cancer stem cell maintenance, tumorigenesis, and suppresses anti-tumor immunity in gastric cancer. Oncology research (2025) |
Extend the Value of Your Mouse Models with Integrated Preclinical Services
GemPharmatech not only provides access to advanced genetically engineered mouse models but also offers comprehensive preclinical research services to help you maximize their value. Our scientific team can support your studies from model construction through phenotype validation and pharmacology testing, ensuring that every experiment is designed for translational relevance. By pairing this conditional knockout model with GemPharmatech’s preclinical services, you gain an integrated workflow that accelerates discovery, reduces risk, and produces robust, actionable data.